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The Human and Mouse Linked Evaluation of Tumors Core (HAMLET) uses human breast tissue 
xenografting techniques to propagate breast cancers in vivo. The new core is led by Professor Matthew 
Ellis, MB, BChir, PhD, Director of Medical Oncology at Washington University and Co-Leader of the 
Breast Cancer Research Program at the Siteman Cancer Center.
The vision of the core is to promote understanding of the biology and genetics of Human Breast Can-
cer by enabling investigators to study tumor cell lines in vivo, which are genetically similar or nearly 
identical to the human tumor from which they originated.
The mouse is an easily manageable system and more closely represents the preferred environment of 
the human tumors, allowing for the hot growth of the tumor soon after it is excised from the human 
donor. This avoids most of the problems and artifacts of attempted in-vitro cultures and faithfully 
reproduces the genomic and phenotypic features of aggressive subtypes of breast cancer, making it a 
valuable research model for preclinical development of biomarkers and imaging techniques, and for 
assessing novel therapeutic approaches.  Whole genome tumor profiling and clinical data linked to 
HAMLET tumor lines is used to validate the models as better preclinical models of the disease than 
standard cell line approaches.
This new research core provides the infrastructure for distributing tumor lines and associated genomic, 
clinical, and pathological data. This approach has already led to exciting results, including a recent pa-
per in Nature (http://www.ncbi.nlm.nih.gov/pubmed/20393555) describing the genomic analyses of 
four DNA samples from a patient with basal-like breast cancer: peripheral blood, the primary tumor, a 
brain metastasis, and a xenograft derived from the primary tumor. The differential mutation frequen-
cies and structural variation patterns in metastasis and xenograft compared with the primary tumor 
indicated that secondary tumors may arise from a minority of cells within the primary tumor.  A future 
Dr. Francis S. Collins, NIH Director, Visits the ICTS
NIH Director, Francis S. Collins, MD, PhD, 
visited the Washington University Medi-
cal Center on June 16th and spoke at the 
dedication ceremony for the BJC Institute 
of Health at Washington University School 
of Medicine.  While on campus, Dr. Collins 
met with ICTS leadership and ICTS member 
investigators to learn about the impact the 
University’s NIH Clinical and Translational 
Science award has had over the last three 
years.  Kenneth S. Polonsky, MD, ICTS 
Director, provided an overview, ICTS core 
directors outlined programmatic efforts and 
individual investigators presented notable 
clinical and translational research accom-
plishments that have received ICTS support.
Left to Right:  Larry J. Shapiro, MD, Victoria J. Fraser, MD, 
FAACP, Francis S. Collins, MD, PhD, Kenneth S. Polonsky, MD, 
and Bradley A. Evanoff, MD, MPH
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BJHF and ICTS Announce the 3rd Annual Clinical and 
Translational Research Funding Program
aim is to extend the HAMLET approach to other tumor types and a discussion on the possibilities of a similar program 
in pancreatic cancer has been initiated.
Services provided by the HAMLET Core that are currently available to ICTS members include:
• Training in procedures to produce and expand Human Breast Cancer Cells in mice
• Archived Washington University Human in Mouse (WHIM) lines
• Tumor lysates from mice
• Nucleic Acid isolated from Human Tumor Lines (DNA, RNA)
• Paraffin-embedded tissue sections WHIM tumors
• Preclinical experiment consultation
For additional information, see the HAMLET webpage at http://www.icts.wustl.edu/cores/hamlet.aspx or or contact Tom 
Kitchens at rkitchen@dom.wustl.edu. 
The Barnes-Jewish Hospital Foundation (BJHF) and the ICTS have partnered again to offer a joint Clinical and Transla-
tional Research Funding Program. The purpose of this program is to fund high-quality, innovative proposals that have 
the potential to advance human health.  Principal Investigators applying for funding must meet RFA eligibility require-
ments, including membership in the ICTS.  Member eligibility information and registration are available at  
http://icts.wustl.edu/membertools/registration.aspx.
Applications will be accepted in two categories:
•	 Planning	Grants: Provide up to $25,000 direct costs for 1 year to facilitate the planning of a new clinical or transla-
tional research project
•	 Research	Grants: Provide up to $75,000 direct costs per year for 1-2 years to support a clinical or translational 
research project 
A town hall meeting to provide investigators the opportunity to ask questions of the ICTS pilot program directors 
(Robert W. Thompson, MD, FACS and Bradley A. Evanoff, MD, MPH) and obtain assistance in developing a competi-
tive proposal will be held on Monday, September 13 from 2:30-3:30 p.m. in the classroom of the ICTS Clinical Research 
Training Center (CRTC), 2nd Floor, Wohl Clinic Building.
We are implementing online Letter of Intent and proposal submission processes this year to automatically collect key 
data items.
The full RFA can be accessed on the ICTS website at http://icts.wustl.edu/funding/bjhf_icts_funding_program.aspx.
Deadlines include:
• Town Hall Q&A Meeting:  September 13, 2010  2:30-3:30 p.m. (CRTC Classroom, 2nd Floor, Wohl Clinic)
• Letter of Intent Due:  September 15, 2010 -- 5:00 p.m. CST
• Applications Due: October 18, 2010 -- 5:00 p.m. CST
• Proposal Peer Review: December, 2010
• Award Start Date: June 1, 2011
Program questions may be addressed to icts@wustl.edu, Jaimee Stagner (ICTS) at 314-362-6325, Becky Evans (ICTS) at 
314-362-9386 or Pamela Jayne (BJHF) at 314-286-0349.  
Technical questions about electronic submission may be addressed to icts@wustl.edu or Jae Allen (ICTS) at 314-362-
9331.
First Grant Recipients of Community/University Health  
Research Partnership Announced
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Edited from the St. Louis Regional Health Commission Press Release of July 21, 2010
The St. Louis Regional Health Commission (RHC) announced the recipients of the first grants from the $1.5 million St. Louis 
Community/University Health Research Partnership (CUHRP), funded by Washington University, Saint Louis University and BJC 
HealthCare.  The initiative, facilitated by the RHC, focuses research efforts on critical health care problems in the St. Louis commu-
nity and supports the development of research partnerships between community-based organizations in St. Louis City and County 
and faculty members at Washington University and Saint Louis University. 
The program awarded seven research partnerships, up to $100,000 per project for a one-year period, to investigate, analyze and 
publicly report findings on an existing health concern within the St. Louis community. Research projects that produce significant 
findings requiring additional funding for program development and implementation may be eligible for a second year of funding.
The 2010 St. Louis Community/University Research Partnership Awardees are:
• Kendra Copanas (Maternal Child and Family Health Coalition) and Pamela Xaverius (SLU)
Advancing Interconception Wellness Among At-Risk Post-Partum Women
• Ben Cooper (Nurses for Newborns) and Nancy Weaver (SLU)
Promoting Safe Environment and Parenting Practices with Home Visitation Programs
• William Hildebrandt (Queen of Peace Center) and Stephen Wernet (SLU)
Evaluation of a Peer Delivered Recovery Management Checkup Model Among Substance Abuse Women
• Joan McGinnis (St. Louis Diabetes Coalition) and Thomas Burroughs (SLU)
Self-Management Education and Support for Diabetes Care Improvement: Linking High-Touch and High-Tech Approaches
• Sherrill Jackson (Breakfast Club Inc) and Mary Politi/Matthew Kreuter (WU)
Connecting Rarely/Never Screened Women to Mammography Via Kiosks and Navigators
• Hannah Reinhart (Gateway Greening) and Susan Racette (WU)
Nourishing an Urban Community II
• Lori Behrens (SIDS Resources) and James Kemp (WU)
Assessing the Delivery of Prevention Messages for Infant Mortality
CUHRP was established in 2009 following two community forums hosted by the RHC to address medical/health research issues in 
the St. Louis community.  At these forums, representatives of Washington University and Saint Louis University outlined several new 
initiatives to improve the interaction between medical/health researchers and the community, including the creation of a new grant-
ing program for community-based organizations with initial funding from universities and affiliated hospitals. In the spring of 2011, 
the RHC will host a forum for the universities to provide an update to the community on the status of their efforts, including the new 
grants.  For more information, visit www.stlrhc.org  or contact Angela Flemming at 314-446-6454 x1011 or afleming@stlrhc.org.
ICTS Community Engagement ARRA Project:  
CTSA Sentinel Network Promotes Study Participation
Reprinted from NCRR Reporter (Spring–Summer 2010 •  Vol. XXXIV, No. 2)
Less than 1 percent of Americans participate in more than 80,000 clinical trials each year, a possible explanation for the difficulty 
researchers face in efforts to reach diverse populations.
To help increase health study participation among underrepresented communities, the Washington University Institute of Clinical 
and Translational Sciences is using ARRA funds for the Sentinel Network for Community-Based Participatory Research project. 
This project aims to include more women and older adults in health research as well as those from racially and ethnically diverse 
backgrounds and from rural regions.
Community health workers at the five CTSA Sentinel Network sites — Albert Einstein College of Medicine of Yeshiva University; 
University of California, Davis; University of Michigan; University of Rochester; and Washington University in St. Louis — are 
working with partner organizations Patient Advocates in Research and Community-Campus Partnerships for Health to find ways to 
increase community participation in clinical research. They also strive to educate community members and provide referrals to area 
health agencies. The Sentinel sites will share results with NCRR, the research community and those who participated in the project.
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Career Development Funding Opportunities 
Applications are currently being accepted for Scholar awards under the ICTS KL2 Mentored Career Development 
Program.  All candidates must have a doctoral-level degree in a discipline that can be applied to clinical research as well 
as a commitment from their department to allow at least 75% of their time to be devoted to didactic and clinical research 
training.  The KL2 program recently received an ARRA supplement that provides funding to extend the program to schol-
ars engaged in Comparative Effectiveness Research (CER), allowing for  two, one-year CER Scholars to be selected in 
addition to the standard KL2 Scholars.
Deadlines/Start Dates
KL2 CER Scholar Applications (1 year) - Due August 18, 2010 for appointments to begin on September 1, 2010.  
KL2 Scholar Applications	(2 year minimum) – Due September 15, 2010 for appointments to begin on July 1, 2011.  
Background 
The ICTS KL2 Mentored Career Development Awards Program arose from the NIH Roadmap K12 Multidisciplinary 
Clinical Research Career Development (MCRCD) awarded in 2005 to Victoria J. Fraser, MD, J. William Campbell Profes-
sor of Medicine, Co-Director Infectious Diseases Division, and Director of the ICTS Clinical Research Training Center.  
The MCRCD initiative of the NIH Roadmap has been a key part of the “Reengineering the Clinical Research Enterprise” 
theme, which seeks to accelerate and strengthen the clinical research process.  Specifically, this initiative’s intent is to 
produce new clinical research leaders who can cross the boundaries of their disciplines and draw upon the strengths of 
other fields.
Before the MCRD K12, this type of multidisciplinary training had not existed at Washington University, but rather each 
department conducted its own training.  In addition, the K12 was unique in that it facilitated collaborative research 
across five institutions – WU, Saint Louis University School of Public Health, St. Louis College of Pharmacy, University 
of Missouri at St. Louis College of Nursing, and Southern Illinois University Edwardsville School of Nursing. In 2007, 
the K12 was rolled into the newly-funded ICTS as the KL2 Mentored Career Development Awards Program.   Dr. Fraser 
continued as the Program Director for the KL2 and was named as the Director of the Clinical Research Training Center 
(CRTC).  
The KL2 program is aimed at fellows, post-doctoral scholars, and junior faculty committed to multidisciplinary clinical 
and translational research. The program provides generous financial support and benefits that allow the scholar to focus 
on didactic studies and mentored research to further their career goals and to contribute to clinical and translational 
science.  Mentors are an integral component of the program and KL2 scholars have been fortunate to receive the benefit of 
their guidance and expertise.
Since the initial cohort of seven scholars in 2006, the program has accepted a total of 35 scholars from a wide variety of 
disciplines including Neurology, Geriatrics and Nutritional Science, Occupational Therapy, Infectious Diseases, Pulmo-
nary and Critical Care, Emergency Medicine, Cardiology, Obstetrics and Gynecology, Public Health, Pediatrics, Psychia-
try, and Surgery.  Under the ICTS, the KL2 remains strong and committed to providing excellent and innovative career 
development to junior investigators.
Submission and Contact Information 
For more information and/or to apply for the current funding opportunities, please visit http://crscholars.wustl.edu or 
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Implementation Research  
Institute Launched at  
Washington University
• Washington University’s ICTS is the featured in-
stitution in the current CTSA national newsletter, 
which can be found at http://www.ncrr.nih.gov/
ctsa/newsletter/currentissue/.  
• James M. Dubois, PhD, DSc, ICTS Director of the 
Center for Clinical Research Ethics (CCRE), and 
Mäder Endowed Professor and Director of the 
Bander Center for Medical Business Ethics at Saint 
Louis University, was the lead author of “Instruction 
in the Reasonable Conduct of Research:  An Inventory 
of the Programs and Materials within CTSA’s,” an ar-
ticle published in the May 2010 issue of the journal, 
CTS-Clinical and Translational Science.
• Learn more about upcoming events, workshops, 
and intra-CTSA university initiatives at the CTSA 
web site at http://www.ctsaweb.org/.
In the News
The Center for Mental Health Services Research, 
within the George Warren Brown School of Social 
Work, received funding to launch an Implementation 
Research Institute (IRI) to advance the field of imple-
mentation science in mental health services research 
(NIMH - R25 MH080916-01A2, 09/09-08/14).  Local 
leadership was provided by Enola Proctor, PhD, PI, 
and Ross Brownson, PhD, core IRI faculty.
Over five years, this $1.2 million grant, augmented 
by the Veteran’s Administration, will bring to our 
University a nationally renowned faculty and over 40 
researchers for intensive training in implementation 
research.  
The  first cohort of fellows and faculty were at the 
Brown School for a week in June for a series of 
workshops and trainings.  Sessions were open only 
to Institute participants, however video recordings 
of many of the presentations will be posted soon for 
streaming download from the IRI web site.  These 
resources will augment the tools available to ICTS 
members through its Dissemination and Implemen-
tation Core (DIRC).
Applications for the next cohort of IRI fellows are due 
January 31, 2011.  Potential applicants, from any-
where in the United States are encouraged to see the 
IRI web site or contact Dr. Proctor at 314-935-5687 or 
cmhsr@brownschool.wustl.edu.
Vicky Holtschlag is the Clini-
cal Laboratory Manager for the 
biospecimen division of the 
ICTS Translational Pathology  
and Molecular Phenotyping 
(TPMP) Core, a joint core with the 
Siteman Tissue Procurement Core.
Vicky works with TPMP Direc-
tor Mark A. Watson, MD, PhD, 
Associate Professor of Patholo-
gy and Immunology, to manage 
quality control processes and administrative services for the 
TPMP.  During the last ten years, she has been instrumen-
tal in helping the tissue bank grow from 5,000 specimens 
to over 200,000. Currently, she manages the translational 
pathology lab, supervising 13 laboratory and technical staff.  
Vicky grew up in Quincy, Illinois and returns home often 
to visit family and friends.  She began her career at Bless-
ing Hospital in Quincy where she became experienced in 
basic clinical laboratory methods and a wide-range of test-
ing technologies.  She worked nights while attending college 
to earn a Bachelor of Science in Biology.  Subsequently, she 
continued her education as a medical technologist, special-
izing in hematology, and earning certification from the 
American Society for Clinical Pathology.  Vicky worked in 
the Barnes-Jewish Hospital flow cytometry laboratory before 
joining Washington University in 2000 in her current posi-
tion as laboratory supervisor for the Laboratory of Transla-
tional Pathology, which includes both the TPMP Core and 
the Siteman Cancer Center Tissue Procurement Core.
The TPMP Core provides biospecimen-related services that 
include processing, tracking, distributing and storing frozen 
tissue, viable cells, plasma serum, and other biofluids.  Blood 
specimens are generally processed to frozen serum aliquots 
and peripheral leukocyte cell pellets.  Other histology and 
molecular services provided include frozen and fixed tissue 
processing and sectioning, and preparing nucleic acid (DNA 
and/or RNA) from tissue and blood biospecimens.  
Investigators interested in utilizing the TPMP Core to help 
support biospecimen collection for their clinical studies 
should arrange to meet with Dr. Watson, Vicky, and other 
members of the TPMP team to discuss their protocol, steps 
to obtain IRB approval for specimen collection, and alloca-
tion of funding to support core services (which may include 
ICTS Just-In-Time funding awards).  Once initiated, Vicky 
and the TPMP Core staff ensure that biospecimens are 
processed according to protocol, inventoried and tracked by 
the core’s secure, web-accessible inventory system (wuTis-
sue), and appropriately preserved for future use (if required 
by the protocol).  
To contact Vicky, email her at vholt@wustl.edu or call 
314-454-7605.  To learn more about how the TPMP Core 
can assist you with your research project, see the ICTS 
website or email tbank@pathbox.wustl.edu.
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ICTS	Brown	Bag	Seminars
August 26 (Noon–1:00 p.m.)  
“My IRB Approval Just Expired—Now What?!”
Martha Jones, MA, CIP, Executive Director, Human Research Protection Office 
Cindy Kiel, JD. CRA. Assistant Vice Chancellor for Research Services and 
Executive Director, Office of Sponsored Research Services; and  
John Michnowicz, Director, Office of Sponsored Research Services
September 28 (Noon–1:00 p.m.)  
“Case Studies in Human Subjects Research Ethics”
James M. Dubois, PhD, DSc, Director of the ICTS Center for Clinical Research 
Ethics (CCRE),  and Mäder Endowed Professor and Director of the Bander Center 
for Medical Business Ethics at Saint Louis University
Holden Auditorium, Farrell Learning and Teaching Center, WU Medical 
School Campus.  Registration is preferred due to limited seating.  WU staff 
register via HRMS Self Service, Training & Development.  Non-WU at-
tendees email ICTS@wustl.edu.  For more information, call 314-362-9829.
 
Clinical	Research	Training	Center	(CRTC)	Seminars
September 7 (2:30-4:00 p.m.) 
“ICTS Cores -- Part I”








Wohl Auditorium, Lower Level, Wohl Hospital Building.
September 14 (2:00-4:00	p.m.	Lecture	with	Reception	After)
CRTC Careeer Development Retreat 
KeyNote Speaker:  David F. Penson, MD, MPH, Director of the 
Center for Surgical Quality & Outcomes Research, Professor of  
Urological Surgery, and Professor of Medicine, Vanderbilt University 
“Recognizing the Right Faculty Position and the Wrong One: 
Strategic Decisions to Build Your Career”
Farrell Learning & Teaching Center, WU Medical School Campus.  
For more information about any CRTC event, contact Julie Headrick at 
jheadric@dom.wustl.edu or call 314-454-8957.
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ICTS Research Navigator Corner
What	is	Translational	Research?
It seems that there are many new buzz words in the world 
of research, and one question that I am often asked is, 
“What exactly is translational research?”  For many, the 
term refers to the “bench-to-bedside” concept of harness-
ing knowledge from basic sciences to produce new drugs, 
devices, and treatment options for patients.  For others 
such as health services researchers and public health in-
vestigators whose studies focus on health care and health 
as the primary outcome, translational research refers 
to translating research into practice where the research 
knowledge actually reaches the populations for whom 
they are intended.  
With that in mind, translational research can be broken 
down as T1, T2 and T3:
T1 Research: The translation of new understandings of 
disease mechanisms gained in the laboratory into the 
development of new methods for diagnosis, therapy, and 
prevention and their initial testing in proof-of-concept 
studies in humans including detailed phenotyping and 
genotyping.
T2 Research: Translation of initial research findings to 
test initial hypotheses and/or approaches in clinical trials, 
including development of evidence-based guidelines.
T3 Research: The translation of results from clinical 
studies into everyday clinical practice and health decision 
making, and identification and resolution of barriers to 
implementation of evidence-based guidelines into com-
munity practice.
For examples of ICTS funded projects, visit the website at 
http:/icts.wustl.edu/funding.  
Contact Sally Anderson, the ICTS Research Navigator, for 
assistance in navigating through the research process. 




Wednesday, September 8, 2010 -- 2:00-3:00 p.m.
“An Overview of the Clinical and Translational  
Science Award & the ICTS”
Sally Anderson, RN, BSN, CCRC, ICTS Research Navigator
Farrell Learning and Teaching Center, Room 214 




Hosted by the Office of Faculty Affairs in the School of Medicine
• September 2:  The ICTS:  An Overview (Sally Anderson, RN, 
BSN, CCRC, ICTS Research Navigator)
• September 9:  ICTS Translational Pathology and Molecular 
Phenotyping Core (Mark Watson, MD, PhD)
• September 16:  ICTS Center for Economic Evaluation of 
Medicine (Steven M. Kymes, PhD)
• September 23:  ICTS Center for Biomedical Informatics 
(Rakesh Nagarajan, MD, PhD)
Schwarz Auditorium, 1st Floor Maternity Building, Washington 
University Medical School Campus.  For more information, 
please contact Karen Dodson at dodsonk@wustl.edu.
